$GRBK
Green Brick Partners, Inc. Stock $grbk

$grbk Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000137367018000029 Filed on August 06, 2018

Income Statement

Concept	2018 Q2	2017 Q2
Revenue	$157.3M	$105.8M
YoY Change	48.76%	6.89%
Cost Of Revenue	$116.2M	$82.00M
YoY Change	41.76%	6.77%
Gross Profit	$41.07M	$23.03M
YoY Change	78.33%	4.14%
Gross Profit Margin	26.11%	21.78%
Selling, General & Admin	$20.02M	$4.167M
YoY Change	380.39%	-1.98%
% of Gross Profit	48.74%	18.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$640.0K	$80.00K
YoY Change	700.0%	33.33%
% of Gross Profit	1.56%	0.35%
Operating Expenses	$20.02M	$4.167M
YoY Change	380.39%	-1.98%
Operating Profit	$21.05M	$13.43M
YoY Change	56.8%	8.91%
Interest Expense	$2.300M	$0.00
YoY Change
% of Operating Profit	10.92%	0.0%
Other Income/Expense, Net	$898.0K	$386.0K
YoY Change	132.64%	-70.76%
Pretax Income	$24.23M	$13.81M
YoY Change	75.41%	1.21%
Income Tax	$5.235M	$4.382M
% Of Pretax Income	21.61%	31.72%
Net Earnings	$14.87M	$7.689M
YoY Change	93.38%	14.03%
Net Earnings / Revenue	9.45%	7.27%
Basic Earnings Per Share	$0.29	$0.16
Diluted Earnings Per Share	$0.29	$0.16
COMMON SHARES
Basic Shares Outstanding	50.66M shares	49.05M shares
Diluted Shares Outstanding	50.78M shares	49.12M shares

Balance Sheet

Concept	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$37.10M	$27.30M
YoY Change	35.9%	13.28%
Cash & Equivalents	$41.20M	$27.30M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$581.4M	$434.6M
Prepaid Expenses
Receivables	$6.200M	$2.400M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$624.7M	$464.3M
YoY Change	34.55%	13.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.454M	$720.0K
YoY Change	379.72%	-10.0%
Goodwill	$680.0K
YoY Change
Intangibles	$275.0K
YoY Change
Long-Term Investments	$19.49M
YoY Change
Other Assets	$27.00M	$65.00M
YoY Change	-58.46%	-15.69%
Total Long-Term Assets	$80.35M	$90.02M
YoY Change	-10.75%	-7.76%
TOTAL ASSETS
Total Short-Term Assets	$624.7M	$464.3M
Total Long-Term Assets	$80.35M	$90.02M
Total Assets	$705.0M	$554.3M
YoY Change	27.19%	9.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.50M	$16.30M
YoY Change	19.63%	-2.4%
Accrued Expenses	$21.10M	$14.40M
YoY Change	46.53%	58.24%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$74.60M	$50.00M
YoY Change	49.2%	39.28%
LONG-TERM LIABILITIES
Long-Term Debt	$174.3M	$84.20M
YoY Change	107.01%	16.14%
Other Long-Term Liabilities	$600.0K	$8.600M
YoY Change	-93.02%	-41.5%
Total Long-Term Liabilities	$174.9M	$92.80M
YoY Change	88.47%	6.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$74.60M	$50.00M
Total Long-Term Liabilities	$174.9M	$92.80M
Total Liabilities	$242.8M	$142.9M
YoY Change	69.97%	5.29%
SHAREHOLDERS EQUITY
Retained Earnings	$152.0M	$124.8M
YoY Change	21.76%
Common Stock	$291.3M	$275.1M
YoY Change	5.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00
YoY Change
Treasury Stock Shares
Shareholders Equity	$443.3M	$399.9M
YoY Change
Total Liabilities & Shareholders Equity	$705.0M	$554.3M
YoY Change	27.19%	9.57%

Cashflow Statement

Concept	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	$14.87M	$7.689M
YoY Change	93.38%	14.03%
Depreciation, Depletion And Amortization	$640.0K	$80.00K
YoY Change	700.0%	33.33%
Cash From Operating Activities	$7.920M	-$12.88M
YoY Change	-161.49%	-228.03%
INVESTING ACTIVITIES
Capital Expenditures	-$580.0K	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$26.10M
YoY Change
Cash From Investing Activities	-$26.68M	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	21.11M	6.820M
YoY Change	209.53%	-170.6%
NET CHANGE
Cash From Operating Activities	7.920M	-12.88M
Cash From Investing Activities	-26.68M	0.000
Cash From Financing Activities	21.11M	6.820M
Net Change In Cash	2.350M	-6.060M
YoY Change	-138.78%	-2524.0%
FREE CASH FLOW
Cash From Operating Activities	$7.920M	-$12.88M
Capital Expenditures	-$580.0K	$0.00
Free Cash Flow	$8.500M	-$12.88M
YoY Change	-165.99%	-226.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001373670
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50719884	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Green Brick Partners, Inc.
	grbk	Amortizationof Deferred Stock Compensation Amount AmortizationofDeferredStockCompensationAmount	197000	USD
	grbk	Contractwith Customer Primary Revenue Sources ContractwithCustomerPrimaryRevenueSources	2	source
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Accounts Payable EquityMethodInvestmentSummarizedFinancialInformationAccountsPayable	5060000	USD
CY2018Q2	grbk	Equity Method Investment Summarized Financial Information Accounts Payable EquityMethodInvestmentSummarizedFinancialInformationAccountsPayable	3428000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Accounts Receivable EquityMethodInvestmentSummarizedFinancialInformationAccountsReceivable	1494000	USD
CY2018Q2	grbk	Equity Method Investment Summarized Financial Information Accounts Receivable EquityMethodInvestmentSummarizedFinancialInformationAccountsReceivable	73000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Accrued Expensesand Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationAccruedExpensesandOtherLiabilities	2857000	USD
CY2018Q2	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Year Three LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsYearThree	25858000	USD
CY2018Q2	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Year Two LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsYearTwo	113077000	USD
CY2017Q4	grbk	Lotsunder Purchase Options Number LotsunderPurchaseOptionsNumber	1724	lot
CY2018Q2	grbk	Lotsunder Purchase Options Number LotsunderPurchaseOptionsNumber	2402	lot
CY2018Q2	grbk	Operating Leases Future Minimum Payments Duein Five Yearsand Thereafter OperatingLeasesFutureMinimumPaymentsDueinFiveYearsandThereafter	1026000	USD
	grbk	Stockholders Equity Including Portion Attributableto Noncontrolling Interest Distributions StockholdersEquityIncludingPortionAttributabletoNoncontrollingInterestDistributions	10423000	USD
CY2017Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	22354000	USD
CY2018Q2	grbk	Equity Method Investment Summarized Financial Information Accrued Expensesand Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationAccruedExpensesandOtherLiabilities	4899000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Cash EquityMethodInvestmentSummarizedFinancialInformationCash	3981000	USD
CY2018Q2	grbk	Equity Method Investment Summarized Financial Information Cash EquityMethodInvestmentSummarizedFinancialInformationCash	11507000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Goodwill EquityMethodInvestmentSummarizedFinancialInformationGoodwill	4615000	USD
CY2018Q2	grbk	Equity Method Investment Summarized Financial Information Goodwill EquityMethodInvestmentSummarizedFinancialInformationGoodwill	4615000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Inventory EquityMethodInvestmentSummarizedFinancialInformationInventory	57841000	USD
CY2018Q2	grbk	Equity Method Investment Summarized Financial Information Inventory EquityMethodInvestmentSummarizedFinancialInformationInventory	57967000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Noncompete Intangible Asset EquityMethodInvestmentSummarizedFinancialInformationNoncompeteIntangibleAsset	202000	USD
CY2018Q2	grbk	Equity Method Investment Summarized Financial Information Noncompete Intangible Asset EquityMethodInvestmentSummarizedFinancialInformationNoncompeteIntangibleAsset	173000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Notes Payable EquityMethodInvestmentSummarizedFinancialInformationNotesPayable	36923000	USD
CY2018Q2	grbk	Equity Method Investment Summarized Financial Information Notes Payable EquityMethodInvestmentSummarizedFinancialInformationNotesPayable	37971000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	5098000	USD
CY2018Q2	grbk	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	5503000	USD
	grbk	Increase Decrease In Inventories Not Owned IncreaseDecreaseInInventoriesNotOwned	1316000	USD
	grbk	Increase Decrease In Inventories Not Owned IncreaseDecreaseInInventoriesNotOwned	0	USD
CY2017Q4	grbk	Inventory Finished Homesand Land Heldfor Sale InventoryFinishedHomesandLandHeldforSale	106043000	USD
CY2018Q2	grbk	Inventory Finished Homesand Land Heldfor Sale InventoryFinishedHomesandLandHeldforSale	144935000	USD
CY2017Q4	grbk	Inventory Homesunder Constructionand Landunder Development InventoryHomesunderConstructionandLandunderDevelopment	390011000	USD
CY2018Q2	grbk	Inventory Homesunder Constructionand Landunder Development InventoryHomesunderConstructionandLandunderDevelopment	436433000	USD
CY2018Q2	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Remainderof Fiscal Year LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsRemainderofFiscalYear	118867000	USD
CY2018Q2	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Total LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsTotal	272292000	USD
CY2018Q2	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Year Five LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsYearFive	2360000	USD
CY2018Q2	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Year Four LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsYearFour	12130000	USD
CY2018Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	19501000	USD
CY2017Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1605000	USD
CY2018Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	6205000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	18465000	USD
CY2018Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	21128000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	289938000	USD
CY2018Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	290842000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	143000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	200000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2072000	USD
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	200000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1421000	USD
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2018Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19000	shares
CY2017Q4	us-gaap	Assets Assets	611003000	USD
CY2018Q2	us-gaap	Assets Assets	705049000	USD
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	0	USD
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-100000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	USD
CY2018Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	628000	USD
CY2016Q4	us-gaap	Cash Cash	35157000	USD
CY2017Q2	us-gaap	Cash Cash	27297000	USD
CY2017Q4	us-gaap	Cash Cash	36684000	USD
CY2018Q2	us-gaap	Cash Cash	37069000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39602000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31771000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40289000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41201000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7831000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	912000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50598901	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50719884	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50598901	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50719884	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	506000	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	507000	USD
CY2017Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1921000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3490000	USD
CY2018Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5428000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	7252000	USD
CY2017Q2	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
CY2018Q2	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
CY2017Q2	us-gaap	Cost Of Real Estate Sales CostOfRealEstateSales	82025000	USD
	us-gaap	Cost Of Real Estate Sales CostOfRealEstateSales	160076000	USD
CY2018Q2	us-gaap	Cost Of Real Estate Sales CostOfRealEstateSales	120392000	USD
	us-gaap	Cost Of Real Estate Sales CostOfRealEstateSales	221527000	USD
CY2017Q2	us-gaap	Costs Of Real Estate Services And Land Sales CostsOfRealEstateServicesAndLandSales	3472000	USD
	us-gaap	Costs Of Real Estate Services And Land Sales CostsOfRealEstateServicesAndLandSales	7762000	USD
CY2018Q2	us-gaap	Costs Of Real Estate Services And Land Sales CostsOfRealEstateServicesAndLandSales	8076000	USD
	us-gaap	Costs Of Real Estate Services And Land Sales CostsOfRealEstateServicesAndLandSales	14702000	USD
CY2016Q4	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	14088000	USD
CY2017Q2	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	19292000	USD
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2017Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1227000	USD
CY2018Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1105000	USD
CY2017Q4	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	21447000	USD
CY2018Q2	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	33988000	USD
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1958000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	31211000	USD
CY2018Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	22891000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	73231000	USD
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	79838000	USD
CY2017Q2	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	0	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.317
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.319
CY2018Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.216
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.211
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7024000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	8320000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	172000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1038000	USD
CY2017Q4	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	22038000	USD
CY2018Q2	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	25451000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	0	USD
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	39099000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	69020000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	28391000	USD
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	33540000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	11799000	USD
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	14392000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	44840000	USD
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	46298000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	73231000	USD
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	79838000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Minority Interest EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest	16592000	USD
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Minority Interest EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest	19148000	USD
CY2017Q2	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	0	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	0	USD
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	4854000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	7932000	USD
CY2017Q2	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	0	USD
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	0	USD
CY2018Q2	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	43953000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	76952000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	16878000	USD
CY2018Q2	us-gaap	Equity Method Investments EquityMethodInvestments	19490000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	0	USD
CY2018Q2	us-gaap	Goodwill Goodwill	1725000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	22926000	USD
	us-gaap	Gross Profit GrossProfit	44212000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	34618000	USD
	us-gaap	Gross Profit GrossProfit	61748000	USD
CY2017Q2	us-gaap	Home Building Costs HomeBuildingCosts	78553000	USD
	us-gaap	Home Building Costs HomeBuildingCosts	152314000	USD
CY2018Q2	us-gaap	Home Building Costs HomeBuildingCosts	112316000	USD
	us-gaap	Home Building Costs HomeBuildingCosts	206825000	USD
CY2017Q2	us-gaap	Home Building Revenue HomeBuildingRevenue	100345000	USD
	us-gaap	Home Building Revenue HomeBuildingRevenue	193742000	USD
CY2018Q2	us-gaap	Home Building Revenue HomeBuildingRevenue	143878000	USD
	us-gaap	Home Building Revenue HomeBuildingRevenue	264244000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13813000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25928000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	24230000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	40841000	USD
CY2017Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2018Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2279000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3815000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4382000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8271000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5235000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8607000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2206000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1579000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1222000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-7073000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-67000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4391000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	138000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1507000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	5204000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	3468000	USD
	us-gaap	Increase Decrease In Earnest Money Deposits Outstanding IncreaseDecreaseInEarnestMoneyDepositsOutstanding	3174000	USD
	us-gaap	Increase Decrease In Earnest Money Deposits Outstanding IncreaseDecreaseInEarnestMoneyDepositsOutstanding	2894000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	25582000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	43439000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1063000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	635000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2018Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	275000	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2017Q4	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	496054000	USD
CY2018Q2	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	581368000	USD
CY2017Q4	us-gaap	Inventory Real Estate InventoryRealEstate	496054000	USD
CY2018Q2	us-gaap	Inventory Real Estate InventoryRealEstate	581368000	USD
CY2017Q2	us-gaap	Land Sales LandSales	4606000	USD
	us-gaap	Land Sales LandSales	10546000	USD
CY2018Q2	us-gaap	Land Sales LandSales	11132000	USD
	us-gaap	Land Sales LandSales	19031000	USD
CY2017Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	200000	USD
CY2018Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	200000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	177965000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	242845000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	611003000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	705049000	USD
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	0	USD
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	100000	USD
CY2017Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	105773000	USD
CY2018Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	166395000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	105773000	USD
CY2018Q2	us-gaap	Long Term Debt LongTermDebt	166395000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	16691000	USD
CY2018Q2	us-gaap	Minority Interest MinorityInterest	12208000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11568000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40493000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27280000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3737000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12301000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	7689000	USD
	us-gaap	Net Income Loss NetIncomeLoss	13886000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	14869000	USD
	us-gaap	Net Income Loss NetIncomeLoss	26072000	USD
CY2017Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1742000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3771000	USD
CY2018Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4126000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6162000	USD
CY2018Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	222000	USD
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	32012000	USD
CY2017Q4	us-gaap	Notes Payable NotesPayable	9926000	USD
CY2018Q2	us-gaap	Notes Payable NotesPayable	1205000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	13427000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	25000000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	20601000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	34968000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4432000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	795000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1033000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1023000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	555000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	2124000	USD
CY2018Q2	us-gaap	Other Assets OtherAssets	2989000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	386000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	928000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1350000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2058000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	70000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	150000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	586000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	412000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	25347000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	755000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1178000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	9470000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	10423000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	27500000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	95500000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	293000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	9431000	USD
	us-gaap	Profit Loss ProfitLoss	17657000	USD
CY2018Q2	us-gaap	Profit Loss ProfitLoss	18995000	USD
	us-gaap	Profit Loss ProfitLoss	32234000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	804000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3454000	USD
CY2016Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	9417000	USD
CY2017Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	9435000	USD
CY2017Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	9425000	USD
CY2017Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	10474000	USD
CY2018Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	11221000	USD
CY2018Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	12143000	USD
CY2017Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	895000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	1770000	USD
CY2018Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	1084000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	1965000	USD
CY2017Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	885000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	1778000	USD
CY2018Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	2006000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	3634000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	USD
CY2018Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	6672000	USD
CY2018Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	6346000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	28500000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	35000000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	735000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	9022000	USD
CY2016Q4	us-gaap	Restricted Cash RestrictedCash	4445000	USD
CY2017Q2	us-gaap	Restricted Cash RestrictedCash	4474000	USD
CY2017Q4	us-gaap	Restricted Cash RestrictedCash	3605000	USD
CY2018Q2	us-gaap	Restricted Cash RestrictedCash	4132000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	125903000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	151975000	USD
CY2018Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	24422000	USD
CY2018Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	48445000	USD
CY2018Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	24766000	USD
CY2018Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4550000	USD
CY2018Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	102183000	USD
	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod	P6M
	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod	P1Y
	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod	P1Y
	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod	P1Y
	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod
CY2017Q2	us-gaap	Revenues Revenues	104951000	USD
	us-gaap	Revenues Revenues	204288000	USD
CY2018Q2	us-gaap	Revenues Revenues	155010000	USD
	us-gaap	Revenues Revenues	283275000	USD
CY2017Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	5332000	USD
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	10767000	USD
CY2018Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	6737000	USD
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	13675000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4167000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8445000	USD
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7280000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13105000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	140000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.45
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	38000	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	34000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	10.25
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	12.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	144000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	10.03
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	300000	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.49
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.00
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1155000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	500000	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	500000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.49
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.49
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	693000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M27D
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	200000	shares
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	200000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.00
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.88
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.88
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M27D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.00
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	669000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	416347000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	443324000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	433038000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	455532000	USD
CY2018Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	104000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	104000	USD
CY2017Q4	us-gaap	Variable Interest Entity Consolidated Assets Not Pledged VariableInterestEntityConsolidatedAssetsNotPledged	56100000	USD
CY2018Q2	us-gaap	Variable Interest Entity Consolidated Assets Not Pledged VariableInterestEntityConsolidatedAssetsNotPledged	57800000	USD
CY2017Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	76000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	67000	shares
CY2018Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	119000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	131000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49123000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49070000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50783000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50751000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49047000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49003000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50664000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50620000	shares
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Basis of Presentation</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) as set forth in the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) and applicable regulations of the Securities and Exchange Commission (“SEC”), but do not include all of the information and footnotes required for complete financial statements. In the opinion of management, the accompanying condensed consolidated financial statements for the periods presented reflect all adjustments, of a normal, recurring nature necessary to fairly state our financial position, results of operations and cash flows. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Our operating results for the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for any future periods.</font></div></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Reclassifications</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to the current period presentation.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes, including the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001373670-18-000029-index-headers.html	Edgar Link	pending
0001373670-18-000029-index.html	Edgar Link	pending
0001373670-18-000029.txt	Edgar Link	pending
0001373670-18-000029-xbrl.zip	Edgar Link	pending
a630201810-qgrbk.htm	Edgar Link	pending
exhibit311certificationofc.htm	Edgar Link	pending
exhibit312certificationofc.htm	Edgar Link	pending
exhibit321certificationofc.htm	Edgar Link	pending
exhibit322certificationofc.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
grbk-20180630.xml	Edgar Link	completed
grbk-20180630.xsd	Edgar Link	pending
grbk-20180630_cal.xml	Edgar Link	unprocessable
grbk-20180630_def.xml	Edgar Link	unprocessable
grbk-20180630_lab.xml	Edgar Link	unprocessable
grbk-20180630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GRBK
Green Brick Partners, Inc. Stock $grbk

2018 Q2 Form 10-Q Financial Statement

#000137367018000029 Filed on August 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRBK Green Brick Partners, Inc. Stock $grbk

2018 Q2 Form 10-Q Financial Statement

#000137367018000029 Filed on August 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRBK
Green Brick Partners, Inc. Stock $grbk